BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12544071)

  • 21. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
    Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO
    Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
    Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).
    Li Y; Li X; Li D; Lu J; Xing X; Yan F; Li Y; Wang X; Iezzi R; De Cobelli F
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):847-54. PubMed ID: 23042922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
    Grazioli L; Morana G; Caudana R; Benetti A; Portolani N; Talamini G; Colombari R; Pirovano G; Kirchin MA; Spinazzi A
    Invest Radiol; 2000 Jan; 35(1):25-34. PubMed ID: 10639033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-site evaluation of liver lesion detection by Gd-BOPTA-enhanced MR imaging.
    Gehl HB; Bourne M; Grazioli L; Möller A; Lodemann KP
    Eur Radiol; 2001; 11(2):187-92. PubMed ID: 11218012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
    Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
    J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study.
    Messina C; Albano D; Orlandi D; Chianca V; Corazza A; Ferrari F; Gitto S; Sconfienza LM
    BMC Med Imaging; 2019 Oct; 19(1):83. PubMed ID: 31653206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies.
    Knopp MV; Schoenberg SO; Rehm C; Floemer F; von Tengg-Kobligk H; Bock M; Hentrich HR
    Invest Radiol; 2002 Dec; 37(12):706-15. PubMed ID: 12447005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of gadoxetic acid to gadobenate dimeglumine for assessment of biliary anatomy of potential liver donors.
    Lewis S; Vasudevan P; Chatterji M; Besa C; Jajamovich G; Facciuto M; Taouli B
    Abdom Radiol (NY); 2016 Jul; 41(7):1300-9. PubMed ID: 26960727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v.
    Yao WW; Zhang HW; M YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
    Technol Cancer Res Treat; 2024; 23():15330338241260331. PubMed ID: 38860337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
    Colosimo C; Knopp MV; Barreau X; Gérardin E; Kirchin MA; Guézénoc F; Lodemann KP
    Neuroradiology; 2004 Aug; 46(8):655-65. PubMed ID: 15205859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA.
    Vernuccio F; Bruno A; Costanzo V; Bartolotta TV; Vieni S; Midiri M; Salvaggio G; Brancatelli G
    Curr Probl Diagn Radiol; 2020; 49(6):398-403. PubMed ID: 31253462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.